The clinical status of irinotecan (CPT-11), a novel water soluble camptothecin analogue: 1996-Reference-Cited by-同舟云学术

The clinical status of irinotecan (CPT-11), a novel water soluble camptothecin analogue: 1996

Published:1996-09 Issue:1 Volume:24 Page:47-70
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

O'Reilly Seamus,Rowinsky Eric K.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference206 articles.

1. Camptothecin and Taxol: Discovery to Clinic — Thirteenth Bruce F Cain Memorial Award Lecture;Wall;Cancer Res,1995

2. Phase I clinical trial of weekly and daily treatment with camptothecin (NSC 100880). Correlation with preclinical studies;Muggia;Cancer Chemother Rep,1972

3. Treatment of malignant melanoma with camptothecin (NSC-100880);Gottlieb;Cancer Chemother Rep,1972

4. Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer;Moertel;Cancer Chemother Rep,1972

5. Antileukemic activity of new camptothecin derivatives;Yokokura,1981

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, Docking, and Machine Learning Studies of Some Novel Quinolinesulfonamides–Triazole Hybrids with Anticancer Activity;Molecules;2024-07-02

2. Irinotecan dosing and pharmacogenomics: a comprehensive exploration based on UGT1A1 variants and emerging insights;Journal of Chemotherapy;2024-05-06

3. Full-profile pharmacokinetics, anticancer activity and toxicity of an extended release trivalent PEGylated irinotecan prodrug;Acta Pharmaceutica Sinica B;2023-08

4. Design, Synthesis and Biological Evaluation of Quinoline-8-Sulfonamides as Inhibitors of the Tumor Cell-Specific M2 Isoform of Pyruvate Kinase: Preliminary Study;Molecules;2023-03-09

5. Synthesis, Structural Elucidation, and Anti-Inflammatory Activity of a Water-Soluble Derivative of Arctiin;Molecules;2023-02-14